In the first week of January, figures show that acute respiratory illnesses rose by 20 percent and influenza-like illnesses by 50 percent compared to the last week of the year, meaning that the flu epidemic has started to spread, and the number of RSV cases has also reached this level, according to press reports.
A-Lab Pharma was the first to market a combined, 4-in-1, population self-sampling registered therapeutic tool to the general public from November 2022, paving the way for the rapid identification of the right viruses during the November-March tridemia season.
Read more about the tridiem here.
Protect your family and loved ones, test regularly with new combined tests until mid-March!
Look for the combined tests of RapiChek in pharmacies or webshops in the webshop!